DecisionRx and BeneCard PBF Unite to Transform Pharmacy Benefits Through Personalized Medication Optimization In a bold move poised to reshape how pharmacy benefits are delivered and experienced across the U.S.,…
AGC Biologics’ Heidelberg Facility to Manufacture Drug Substance for Phase II Trials of Valneva’s Four-Valent Shigella Vaccine Candidate AGC Biologics, a global contract development and manufacturing organization (CDMO), announced a…
IntraBio’s AQNEURSA® Gains CHMP Recommendation for Niemann-Pick Disease Type C, Signaling Major Breakthrough in Rare Neurological Disorder Treatment In a landmark development for the rare disease community, IntraBio Inc., a…
Avance Clinical Ushers in a New Era of Trial Excellence Through Strategic Digital Validation Partnership with ValGenesis In a strategic move set to redefine the landscape of clinical research quality…
Simulations Plus and Polish Academy Scientists Validate AI-Powered Drug Design Models in Breakthrough Discovery Targeting Inflammation and Immune Regulation Simulations Plus, Inc. (Nasdaq: SLP), a prominent developer of modeling and…
Compass Pathways Appoints Biopharmaceutical Veteran Justin Gover to Board of Directors as Company Advances Toward Potential Regulatory Milestone Compass Pathways plc (Nasdaq: CMPS), a biotechnology company at the forefront of…
Centauri Therapeutics Secures Additional $5.1M from CARB-X to Propel Lead Antibacterial Candidate ABX-01 Into First-in-Human Trials Centauri Therapeutics Limited, an innovative immunotherapy company leveraging a novel platform for combating infectious…
Bio-Rad Laboratories Appoints Rajat Mehta as Executive Vice President of Global Commercial Operations, Marking a New Era in Strategic Leadership Herculean succession marks leadership transition following the retirement of Mike…
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Early-Stage Lung Cancer, Expanding Its Role in Perioperative NSCLC Treatment BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global…
Biocytogen Elevates Preclinical Research Services and Global Engagement with Strategic Platform Upgrade and Website Relaunch Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKEX: 02315), a pioneering force in the biotechnology sector known…
MaaT Pharma Secures €37.5 Million EIB Loan to Propel Hemato-Oncology Pipeline and Microbiome Therapy Leadership MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotechnology company pioneering Microbiome Ecosystem Therapies™ (MET) to improve…
Genentech and Roche Unveil Comprehensive Advances in Alzheimer’s Disease Research at AAIC 2025 At the 2025 Alzheimer’s Association International Conference (AAIC), held in Toronto from July 27 to 30, Genentech…